{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:40Z","timestamp":1761630700138},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T00:00:00Z","timestamp":1413158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Swedish Child Diabetes Foundation, and the Swedish Research Council","award":["K2011-65X-3031-01-6"],"award-info":[{"award-number":["K2011-65X-3031-01-6"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title \/>\n                  <jats:p>Multipotent mesenchymal stromal cell (MSC) therapy and costimulation blockade are two immunomodulatory strategies being developed concomitantly for the treatment of immunological diseases. Both of these strategies have the capacity to inhibit immune responses and induce regulatory T cells; however, their ability to synergize remains largely unexplored. In order to study this, MSCs from C57BL\/6 (H2b) mice were infused together with fully major histocompatibility complex-mismatched Balb\/c (H2d) allogeneic islets into the portal vein of diabetic C57BL\/6 (H2b) mice, which were subsequently treated with costimulation blockade for the first 10 days after transplantation. Mice receiving both recipient-type MSCs, CTLA4Ig, and anti-CD40L demonstrated indefinite graft acceptance, just as did most of the recipients receiving MSCs and CTLA4Ig. Recipients of MSCs only rejected their grafts, and fewer than one half of the recipients treated with costimulation blockade alone achieved permanent engraftment. The livers of the recipients treated with MSCs plus costimulation blockade contained large numbers of islets surrounded by Foxp3+ regulatory T cells. These recipients showed reduced antidonor IgG levels and a glucose tolerance similar to that of na\u00efve nondiabetic mice. Intrahepatic lymphocytes and splenocytes from these recipients displayed reduced proliferation and interferon-\u03b3 production when re-exposed to donor antigen. MSCs in the presence of costimulation blockade prevented dendritic cell maturation, inhibited T cell proliferation, increased Foxp3+ regulatory T cell numbers, and increased indoleamine 2,3-dioxygenase activity. These results indicate that MSC infusion and costimulation blockade have complementary immune-modulating effects that can be used for a broad number of applications in transplantation, autoimmunity, and regenerative medicine.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5966\/sctm.2014-0012","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T02:01:44Z","timestamp":1413252104000},"page":"1484-1494","source":"Crossref","is-referenced-by-count":18,"title":["Multipotent Mesenchymal Stromal Cells Synergize With Costimulation Blockade in the Inhibition of Immune Responses and the Induction of Foxp3+ Regulatory T Cells"],"prefix":"10.1093","volume":"3","author":[{"given":"Tohru","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Transplantation Surgery, Karolinska Institutet, CLINTEC, Stockholm, Sweden"},{"name":"Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Tibell","sequence":"additional","affiliation":[{"name":"Division of Transplantation Surgery, Karolinska Institutet, CLINTEC, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Ljung","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Transplantation Surgery, Karolinska Institutet, CLINTEC, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gronlund","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Osterholm","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Holgersson","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Transfusion Medicine, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torbj\u00f6rn","family":"Lundgren","sequence":"additional","affiliation":[{"name":"Division of Transplantation Surgery, Karolinska Institutet, CLINTEC, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-G\u00f6ran","family":"Ericzon","sequence":"additional","affiliation":[{"name":"Division of Transplantation Surgery, Karolinska Institutet, CLINTEC, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Corbascio","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery and Anesthesiology, Karolinksa University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Kumagai-Braesch","sequence":"additional","affiliation":[{"name":"Division of Transplantation Surgery, Karolinska Institutet, CLINTEC, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,10,13]]},"reference":[{"key":"2021122710021928400_R1","doi-asserted-by":"crossref","first-page":"a007823","DOI":"10.1101\/cshperspect.a007823","article-title":"Update on islet transplantation","volume":"2","author":"McCall","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2021122710021928400_R2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122710021928400_R3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am J Transplant"},{"key":"2021122710021928400_R4","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells","volume":"181","author":"Casiraghi","year":"2008","journal-title":"J Immunol"},{"key":"2021122710021928400_R5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/307168a0","article-title":"Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts","volume":"307","author":"Ildstad","year":"1984","journal-title":"Nature"},{"key":"2021122710021928400_R6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"2021122710021928400_R7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"2021122710021928400_R8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2021122710021928400_R9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: Sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2021122710021928400_R10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"2021122710021928400_R11","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.4049\/jimmunol.1202775","article-title":"Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines","volume":"190","author":"Chen","year":"2013","journal-title":"J Immunol"},{"key":"2021122710021928400_R12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/scrt216","article-title":"Mesenchymal stem cells generate a CD4 +CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells","volume":"4","author":"Luz-Crawford","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"2021122710021928400_R13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/cei.12199","article-title":"Mesenchymal stem cells control alloreactive CD8(+) CD28(\u2212) T cells","volume":"174","author":"Engela","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"2021122710021928400_R14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/TP.0b013e3181b4425a","article-title":"Toward MSC in solid organ transplantation: 2008 Position paper of the MISOT Study Group","volume":"88","author":"Dahlke","year":"2009","journal-title":"Transplantation"},{"key":"2021122710021928400_R15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/TP.0b013e31826d4672","article-title":"Costimulation blockade: Current perspectives and implications for therapy","volume":"95","author":"Kinnear","year":"2013","journal-title":"Transplantation"},{"key":"2021122710021928400_R16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature"},{"key":"2021122710021928400_R17","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.tp.0000244064.66136.04","article-title":"Costimulation blockade-induced cardiac allograft tolerance: Inhibition of T cell expansion and accumulation of intragraft CD4(+)Foxp3(+) T cells","volume":"82","author":"Oderup","year":"2006","journal-title":"Transplantation"},{"key":"2021122710021928400_R18","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI8082","article-title":"Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection","volume":"104","author":"Trambley","year":"1999","journal-title":"J Clin Invest"},{"key":"2021122710021928400_R19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/TP.0b013e31824e75d7","article-title":"Combined costimulatory and leukocyte functional antigen-1 blockade prevents transplant rejection mediated by heterologous immune memory alloresponses","volume":"93","author":"Kitchens","year":"2012","journal-title":"Transplantation"},{"key":"2021122710021928400_R20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2119\/molmed.2010.00098","article-title":"Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts","volume":"17","author":"Kim","year":"2011","journal-title":"Mol Med"},{"key":"2021122710021928400_R21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/TP.0b013e3181c7dc99","article-title":"Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation","volume":"89","author":"Park","year":"2010","journal-title":"Transplantation"},{"key":"2021122710021928400_R22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/08820139.2011.619022","article-title":"Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect","volume":"41","author":"Choi","year":"2012","journal-title":"Immunol Invest"},{"key":"2021122710021928400_R23","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jss.2010.04.044","article-title":"Donor pretreatment with DHMEQ improves islet transplantation","volume":"163","author":"Takahashi","year":"2010","journal-title":"J Surg Res"},{"key":"2021122710021928400_R24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgm.1531","article-title":"Transplantation of CTLA4Ig gene-transduced adipose tissue-derived mesenchymal stem cells reduces inflammatory immune response and improves Th1\/Th2 balance in experimental autoimmune thyroiditis","volume":"13","author":"Choi","year":"2011","journal-title":"J Gene Med"},{"key":"2021122710021928400_R25","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1089\/scd.2013.0248","article-title":"Allogeneic murine mesenchymal stem cells: Migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig","volume":"22","author":"Sullivan","year":"2013","journal-title":"Stem Cells Dev"},{"key":"2021122710021928400_R26","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/TP.0b013e3181db09c4","article-title":"Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function","volume":"89","author":"Ito","year":"2010","journal-title":"Transplantation"},{"key":"2021122710021928400_R27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fimmu.2013.00082","article-title":"Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells","volume":"4","author":"Hubo","year":"2013","journal-title":"Front Immunol"},{"key":"2021122710021928400_R28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/08820139.2011.607877","article-title":"Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells","volume":"41","author":"Zhao","year":"2012","journal-title":"Immunol Invest"},{"key":"2021122710021928400_R29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3727\/096368910X508762","article-title":"Mesenchymal stem cells: Mechanisms of immunomodulation and homing","volume":"19","author":"Yagi","year":"2010","journal-title":"Cell Transplant"},{"key":"2021122710021928400_R30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ni846","article-title":"CTLA-4-Ig regulates tryptophan catabolism in vivo","volume":"3","author":"Grohmann","year":"2002","journal-title":"Nat Immunol"},{"key":"2021122710021928400_R31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/eci.12.79","article-title":"Belatacept: A novel immunosuppressive agent for kidney transplant recipients","volume":"8","author":"Charpentier","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"2021122710021928400_R32","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"2021122710021928400_R33","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.12330","article-title":"ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates","volume":"13","author":"Watanabe","year":"2013","journal-title":"Am J Transplant"},{"key":"2021122710021928400_R34","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/ajt.12082","article-title":"A phase 1, randomized ascending single-dose study of antagonist anti-human CD40 ASKP1240 in healthy subjects","volume":"13","author":"Goldwater","year":"2013","journal-title":"Am J Transplant"},{"key":"2021122710021928400_R35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/978-0-387-89520-8_2","article-title":"Therapeutic interventions targeting CD40L (CD154) and CD40: The opportunities and challenges","volume":"647","author":"Law","year":"2009","journal-title":"Adv Exp Med Biol"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2014-0012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2014-0012","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/3\/12\/1484\/41892373\/stcltm_3_12_1484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/3\/12\/1484\/41892373\/stcltm_3_12_1484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:48:11Z","timestamp":1642560491000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/3\/12\/1484-1494\/6389867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,13]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,10,13]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2014-0012","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,12,1]]},"published":{"date-parts":[[2014,10,13]]}}}